article thumbnail

An Informatics Approach to Preventing Diversion of Controlled Substances

Pharmacy Times

Data analysis can help hospitals address waste of controlled substances that fuels diversion and increased costs.

article thumbnail

How to Leverage the Revised ASHP Guidelines to Prevent the Diversion of Controlled Substances at Hospitals

Pharmacy Times

A controlled substances diversion prevention program (CSDPP) that aligns with the revised ASHP guidelines is critical to ensure patients are protected from occurrences of drug diversion.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Hospitals: Do You Know Where Your Controlled Substances Are?

The FDA Law Blog

Houck — Employee diversion of controlled substances from hospitals has been an issue since at least 1986 when I became a diversion investigator with the Drug Enforcement Administration (“DEA”). DEA alleged that UMHS failed to maintain complete and accurate records and failed to timely notify DEA of controlled substance thefts.

article thumbnail

HPM’s Larry Houck Presenting at WCF Opioid and Fentanyl Abuse Management Congress

The FDA Law Blog

Houck One of the most significant issues facing hospitals and other facilities is the diversion of controlled substances meant for patients by physicians, pharmacists, nurses and other trusted healthcare employees. Click here to learn more about the Opioid & Abuse Management Congress.

article thumbnail

Is cyclobenzaprine a controlled substance?

The Checkup by Singlecare

Many people mistake it for a controlled substance. However, medical experts say this is untrue, as the prescription medication is not classified as a controlled substance by the United States Drug Enforcement Administration (DEA). Is cyclobenzaprine a controlled substance? What is cyclobenzaprine?

article thumbnail

The Power of an End-to-End Controlled Substance Management Program

Omnicell

Gee Mathen, Director Pharmacy Clinical Applications & Technical Services, Texas Children Hospital When it comes to the crippling costs of diversion, the numbers don’t lie: 1 in 10 healthcare workers will abuse drugs, and studies show that the annual impact is upwards of $72.5

article thumbnail

Join Us for an HPM Webinar: Recent Hospital Controlled Substance Diversion Cases — Cautionary Tales; Tuesday, October 3, 2023: 12:00-12:45

The FDA Law Blog

More than 40 registrants — primarily hospitals and pharmacies — have paid significant civil penalties of up to $5,000,000 to settle allegations they failed to report controlled substance thefts or significant losses to the Drug Enforcement Administration (DEA). The risks to hospitals and pharmacies are multi-faceted and growing.